• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Atorvastatin
    5 Drugs classified under this active ingredient


    All the Active Ingredient Drugs

    Atorvastatin Teva
    Teva
    RX
    partial basket chart
    Atorvastatin Teva

    Statin. Atorvastatin 10, 20, 40, 80 mg.
    F.C. TABS: 30 x 10 mg, 20 mg, 40 mg, 80
    mg. Prim. hypercholesterolem. incl.
    famil. hypercholesterolem.
    (heterozygous variant)/comb. (mixed)
    hyperlipidemia (Fredrickson types IIa,
    IIb): Initial: 10-20 mg 1 x dly. Pts. requir.
    large reduct. in LDL (>45%): 40 mg 1 x
    dly. Dos. range: 10-80 mg 1 x dly. To be
    individualiz. Homozygous famil.
    hypercholesterolem: 10-80 mg 1 x dly
    as adjuv. to other lipid-lower. tmt or if
    such tmts unavail. Heterozygous famil.
    hypercholesterolem in ped. pts (10-17
    yrs): Initial: 10 mg dly; max: 20 mg dly.
    To be individualiz. Prevent. CV/
    cerebrovasc. events: 10 mg dly. Higher
    dos. may be necessary. Hepat. insuffic:
    Perform liver tests bef. initiat. tmt, at 6
    and 12 wks aft. initiat./elevat. dose and
    periodic. (e.g. semi-annually). Ren.
    insuffic: No dose adjust. req. Elderly: As
    gen. populat.
    Hypercholesterolem: Adjuv. to diet for
    reduct. elevat. total cholesterol LDLcholesterol
    apolipoprotein B and
    triglycerides and to increase HDL
    cholesterol in pts with prim.
    hypercholesterolem. when response to
    diet and other nonpharmacolog.
    measures is inadeq; to reduce total-C and
    LDL-C in pts. with homozygous familial
    hypercholesterolem. as an adjunct to
    other lipid-lower. tmt. (e.g. LDL apheres.)
    or if such tmts are unavail. Ped. pts (10-17
    yrs): Adjuv. to diet to reduce total -C, LDL-C
    and apo B levels in boys and
    postmenarchal girls with heterozygous
    famil. hypercholesterolem. Prevent. CV
    dis./cerebrovasc. event: Adjuv. to correct.
    other risk factors such as hypertens. Pts.
    with clinic. evident coronary heart dis:
    Reduce risk of non-fatal MI; reduce risk of
    fatal and non fatal stroke; reduce risk of
    hospitalizat. for CHF; reduce risk of
    angina. Reduce risk revascular. proced.
    C/I: Hypersens., active liver dis./
    unexplained persist. elevats. serum
    transaminases exceeding 3 x upper limit
    of normal; myopath., pregn./lact.;
    women of childbear. potent. not using
    approp. contracept. measures.

    Atozet
    MSD
    RX
    partial basket chart
    Multiple ingredients
    Atozet

    HMG-CoA Reductase Inhibitor, Lipid Modifying Agent. Ezetimibe 10 mg, Atorvastatin 10, 20, 40, 80 mg.
    F.C. TABS.: 30. Hypercholesterolaemia and/or CHD with ACS History). The pt. should be on an appropriate lipid-lower. diet and should cont. on this diet during tmt. with this drug.
    The dose range is 10/10 mg/d. through 10/80 mg/d. The typical dose is 10/10 mg ×1/d. The pt’s. low-density lipoprotein cholesterol (LDL-C) level, CHD status, and response to current cholesterol-lower. ther. should be consid. when starting ther. or adjust. the dose.
    The dose should be individual. based on the known efficacy of the various dose strengths of and the response to the current cholesterol-lower. ther. Adjust. of dose should be made at intervals of 4 wks. or more.
    HoFH: 10/10-10/80 mg dly. The drug  may be used as an adjunct to other lipid-lower. tmts. (e.g., LDL apheresis) in these pts. or if such tms. are unavailab.
    May be taken with/without food.
    Prevent. of Cardiovasc. Event: Indicat. to reduce the risk of cardiovasc. events in pts. with coron. heart dis.(CHD) and a hist. of acute coron. syndr. (ACS), either previous. treated with a statin or not.
    Hypercholesterolaemia: The drug  indicat. as adjunct. ther. to diet for use in adult. with prim. (heterozygous famil. and non-famil.) hypercholesterolaemia or mixed hyperlipidaemia where use of a comb. product is appropriate, pts. not appropriat. control. with a statin alone, pts. already treated with a statin and ezetimibe.
    Homozyg. Familial Hypercholesterolaemia (HoFH): Indicat. as adjunct. ther. to diet for use in adults with HoFH. Pts. may also receive adjunct. tmts. (e.g., low-density lipoprotein [LDL] apheresis).
    C/I: Hypersens. Preg., lact. , and in women of child-bear. potent.

    Lipitor
    Pfizer
    RX
    partial basket chart
    Lipitor

    Statin. Atorvastatin (as calcium) 10, 20, 40, 80 mg.
    F.C. TABS: 30 x 10 mg, 20 mg. Init: 10-20-
    mg 1 x dly. Pts requir. larger reduct. in
    LDL (more than 45%) may be started
    at 40 mg 1 x dly. Adjust. dose at
    intervals of 4 wks or more. Max. dose:
    80 mg 1 x dly. Doses may be given at
    any time of day without regard to
    meals. Lipid levels should be analyzed
    within 2-4 wks and dose adjust.
    accord. See lit.
    F.C. TABS: 30 x 40 mg, 80 mg.
    Initial: 10 mg 1 x dly. Incr. grad. to max.
    80 mg 1 x dly without regard to meals.
    Adjunct. to diet for tmt. elevated total
    and LDL cholesterol, apo B, triglyc. in pts.
    with prim. hypercholesterolem.,
    incl.
    famil. hypercholesterolem. (heterozyg.)
    or combined (mixed) hyperlipidemia
    (types IIa, IIb Fredrickson classific.) when
    response to diet and other non-pharm.
    measures alone has been inad. To reduce
    total-C and LDL-C in pts. with homozyg.
    famil. hypercholesterolem. as adjunct to
    other tmts. Ped: 10-17 yrs: Adjunct to diet
    to reduce total-C, LDL-C, apo B levels in
    boys and postmenarchal girls with
    heterozyg. famil. hypercholesterem. aft.
    an adequate trial of diet ther. with foll.
    findings: LDL-C remains ≥ 190 mg/dL or
    LDL-C remains ≥ 160 mg/dL with
    positive fam. history of prem. CV dis. or 2
    or more other CVD risk factors present.
    Prevent CV and/or cerebrovasc. events
    such as MI or stroke. Adjunct to correct
    other risk factors such as hypertens. (in
    pts with 3 or more additional risk factors
    or diabetes with one additional risk
    factor.)
    C/I: Hypersens., active liver dis.,
    unexplained elevat. serum
    transaminase, myopathy, pregn., lact.
    See lit.

    Litorva 10, 20, 40, 80 mg
    Dexcel
    RX
    partial basket chart
    Litorva 10, 20, 40, 80 mg

    Statin. Atorvastatin (as Calcium) 10, 20, 40, 80 mg.
    TABS: 30 X 10 mg, 20 mg, 40 mg, 80 mg.
    Usual Init dose: 10 or 20mg 1 × dly.
    Adjust. Dose at intervals of 4 wks or
    more. Max. dose for adults: 80mg 1xdly.
    Max. dose for children: 20 mg 1Xdly.
    Doses may be given at any time of day
    without regard to meals. Lipid levels
    should be analyzed within 2-4 wks and
    dose adjust. accord. See lit.
    Adjunct. to diet for tmt. elevated total
    and LDL-cholesterol, apo B triglyc. and
    to incr. HDL cholesterol in pts. with
    prim. hypercholesterolem., incl. famil.
    hypercholesterolem. (heterozyg.) or
    combined (mixed) hyperlipidemia
    (types IIa, IIb fredrickson classific.) when
    response to diet and other non-pharm.
    measures alone has been inad. To
    reduce total-C and LDL-C in patients
    with homozyg. famil.
    hypercholesterolem. as adjunct to other
    lipid-lower. tmt. (e.g. LDL apheres.) or if
    such tmts. unavail. Ped: 10-17 yrs:
    Adjunct to diet to reduce total-C, LDL-C,
    apo B levels in boys and postmenarchal
    girls (10-17 yrs of age) with heterozyg.
    famil. hypercholesterolem. aft. an
    adequate trial of diet ther. with foll.
    findings: LDL-C remains > or = 190 mg/
    dl, LDL-C remains > or = 160 mg/dl with
    positive fam. history of prem. CV dis. or
    two or more other CVD risk factors
    present in the pediatric patient. Prevent.
    CV and/or cerebrovasc. events such as
    MI or stroke. Adjunct to correct other
    risk factors such as hypertens. (in pts. with 3 or more additional risk factors or
    diabetes with one additional risk factor).
    Pts. with clinic. evident coronary heart
    dis: Reduce risk of non fatal MI. Reduce
    risk of fatal/non fatal stroke. Reduce risk
    of revasc. proced. Reduce risk of
    hospitalizat. for CHF. Reduce risk of
    angina. See lit.
    C/I: Hypersens. to Atorvastatin or
    ingreds or to similar blood lipid
    lowering. Pregn., Lact. and in woman of
    childbear. age not using adeq.
    contracept. Active or history of liver dis.,
    unexplained presistent elevat. serum
    transaminase exceeding 3 times the
    upper limit of normal. Myopathy. Ped.
    under 10 yrs/ premenstruation girls.
    Patients that take Cyclosporine,
    Telaprevir or a combination of
    Tipranavir and Ritronavir. See lit.

    Torid
    Unipharm
    RX
    partial basket chart
    Torid

    Statin. Atorvastatin 10, 20, 40, 80 mg.
    TABS: 30 x 10 mg, 20 mg. Init: 10-20-
    mg 1 x dly. Pts requir. larger reduct. in
    LDL (more than 45%) may be started at
    40 mg 1 x dly. Adjust. dose at intervals
    of 4 wks or more. Max. dose: 80 mg 1 x
    dly. Doses may be given at any time of
    day without regard to meals. Lipid
    levels should be analyzed within 2-4
    wks and dose adjust. accord. See lit.
    TABS: 30 x 40 mg, 80 mg.
    Initial: 10 mg 1 x dly. Incr. grad. to max.
    80 mg 1 x dly without regard to meals.
    Adjunct. to diet for tmt. elevated total and
    LDL cholesterol, apo B, triglyc. in pts. with
    prim. hypercholesterolem.,
    incl. famil.
    hypercholesterolem. (heterozyg.) or
    combined (mixed) hyperlipidemia (types
    IIa, IIb Fredrickson classific.) when
    response to diet and other non-pharm.
    measures alone has been inad. To reduce
    total-C and LDL-C in pts. with homozyg.
    famil. hypercholesterolem. as adjunct to
    other tmts. Ped: 10-17 yrs: Adjunct to diet
    to reduce total-C, LDL-C, apo B levels in
    boys and postmenarchal girls with
    heterozyg. famil. hypercholesterem. aft. an
    adequate trial of diet ther. with foll.
    findings: LDL-C remains ≥ 190 mg/dL or
    LDL-C remains ≥ 160 mg/dL with positive
    fam. history of prem. CV dis. or 2 or more
    other CVD risk factors present. Prevent CV
    and/or cerebrovasc. events such as MI or
    stroke. Adjunct to correct other risk factors
    such as hypertens. (in pts with 3 or more
    additional risk factors or diabetes with one
    additional risk factor.)
    C/I: Hypersens., active liver dis.,
    unexplained elevat. serum transaminase,
    myopathy, pregn., lact. See lit.

    CLOSE